IMRIS (IMRSQ) LT-Debt-to-Total-Asset: 0.32 (As of Dec. 2014)


What is IMRIS LT-Debt-to-Total-Asset?

IMRIS IMRSQ LT-Debt-to-Total-Asset is 0.32 as of Dec. 2014.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. IMRIS's long-term debt to total assests ratio for the quarter that ended in Dec. 2014 was 0.32.

IMRIS's long-term debt to total assets ratio increased from Dec. 2013 (0.25) to Dec. 2014 (0.32). It may suggest that IMRIS is progressively becoming more dependent on debt to grow their business.

IMRIS  (OTCPK:IMRSQ) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

IMRIS LT-Debt-to-Total-Asset Related Terms

IMRIS LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for IMRIS's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IMRIS LT-Debt-to-Total-Asset Chart

IMRIS Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.25 0.32

IMRIS Quarterly Data
Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.27 0.31 0.35 0.32

IMRIS LT-Debt-to-Total-Asset Calculation

IMRIS's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2014 is calculated as

LT Debt to Total Assets (A: Dec. 2014 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2014 )/Total Assets (A: Dec. 2014 )
=21.026/65.484
=0.32

IMRIS's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2014 is calculated as

LT Debt to Total Assets (Q: Dec. 2014 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2014 )/Total Assets (Q: Dec. 2014 )
=21.026/65.484
=0.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.32 mean?
IMRIS (IMRSQ) has a LT-Debt-to-Total-Asset of 0.32 as of Dec. 2014. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on IMRIS and its competitors.
Is IMRIS's LT-Debt-to-Total-Asset too high?
IMRIS's current LT-Debt-to-Total-Asset is 0.32.
How does IMRIS's LT-Debt-to-Total-Asset compare to IVOB and IGNG?
IMRIS's LT-Debt-to-Total-Asset of 0.32 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Medical Devices & Instruments company?
A good LT-Debt-to-Total-Asset depends on the Medical Devices & Instruments industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on IMRIS and its competitors. IMRIS's current LT-Debt-to-Total-Asset is 0.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IMRIS stock overvalued right now?
IMRIS (IMRSQ) has a current LT-Debt-to-Total-Asset of 0.32. The current LT-Debt-to-Total-Asset is 0.32. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For IMRIS (IMRSQ), the current LT-Debt-to-Total-Asset is 0.32 as of Dec. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

IMRIS Business Description

Address 1230 Chaska Creek Way, Suite 100, Chaska, MN, USA, 55318
IMRIS Inc provides integrated intraoperative imaging environments that deliver real-time MRI and imaging data during surgical and interventional procedures. The Operating Suite of the company enables imaging directly within the OR, enhancing clinical decision-making. The company also designs and manufactures proprietary head fixation devices, imaging coils, and OR tables tailored for this specialized setting.